Multiple Sclerosis Journal

The Multiple Sclerosis Journal (ISSN 1352-4585) is a prestigious monthly peer-reviewed publication based in the United Kingdom and published by SAGE, serving as a leading forum for comprehensive research on multiple sclerosis. As a high-impact journal indexed in the Science Citation Index (SCI), it maintains a strong academic reputation and a competitive submission process, reflecting the rigor of its review standards. The journal’s scope encompasses the full spectrum of multiple sclerosis research, integrating clinical and basic science perspectives to address etiology, pathogenic mechanisms, diagnostic advancements, therapeutic strategies, and rehabilitation management. It publishes a diverse array of scholarly content, including original research articles, comprehensive reviews, and detailed case reports, catering to a global audience of neurologists, immunologists, and researchers dedicated to advancing the understanding and treatment of the disease. While the journal operates under a non-open access model, which may require subscription for full-text access, its standing in the Chinese Academy of Sciences (CAS) journal ranking and its consistent high impact factor underscore its significant influence and authority within the international neuroscience and neurology communities.